NOD2 gene variants are a risk factor for culture-positive spontaneous bacterial peritonitis and monomicrobial bacterascites in cirrhosis

Liver International

Volumn 32, Issue 2, 2012, Pages 223-230

  Bruns, Tony ^a,b   Peter, Jack ^a   Reuken, Philipp A ^a,b   Grabe, Dominik H ^c   Schuldes, Sonja R ^c   Brenmoehl, Julia ^a   Schölmerich, Jürgen ^c   Wiest, Reiner ^c   Stallmach, Andreas ^a,b  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b Integrated Research and Treatment Center for Sepsis Control and Care (CSCC)   (Germany)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Bacterascites; Bacterial translocation; Cirrhosis; Mortality; NOD2 gene; Spontaneous bacterial peritonitis

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASCITES; ASCITES FLUID; BACTERIAL MUTATION; BACTERIAL PERITONITIS; BACTERIUM CULTURE; CANCER SURVIVAL; ESCHERICHIA COLI; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HOSPITAL PATIENT; HUMAN; INFECTION RISK; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MICROCOCCUS; MONOMICROBIAL BACTERASCITES; NEUTROPHIL COUNT; PARACENTESIS; POLYMERASE CHAIN REACTION; SCORING SYSTEM; SPONTANEOUS BACTERIAL PERITONITIS;

ADULT; AGED; AGED, 80 AND OVER; ASCITES; ASCITIC FLUID; BACTERIAL INFECTIONS; BACTERIAL TRANSLOCATION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHILS; NOD2 SIGNALING ADAPTOR PROTEIN; PERITONITIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84855532619     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02561.x     Document Type: Article

References (35)

1. Ginès P, Angeli P, Lenz K, et al. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010; 53: 397-417.
2. Berg RD, Garlington AW. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun 1979; 23: 403-11.
3. Akalin HE, Laleli Y, Telatar H. Bactericidal and opsonic activity of ascitic fluid from cirrhotic and noncirrhotic patients. J Infect Dis 1983; 147: 1011-7.
4. Guarner C, Runyon BA, Young S, Heck M, Sheikh MY. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol 1997; 26: 1372-8.
5. Jun DW, Kim KT, Lee OY, et al. Association between small intestinal bacterial overgrowth and peripheral bacterial DNA in cirrhotic patients. Dig Dis Sci 2010; 55: 1465-71.
6. Scarpellini E, Valenza V, Gabrielli M, et al. Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed? Am J Gastroenterol 2010; 105: 323-7.
7. Woodcock NP, Robertson J, Morgan DR, et al. Bacterial translocation and immunohistochemical measurement of gut immune function. J Clin Pathol 2001; 54: 619-23.
8. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-6.
9. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
10. Fritz JH, Ferrero RL, Philpott DJ, Girardin SE. Nod-like proteins in immunity, inflammation and disease. Nat Immunol 2006; 7: 1250-7.
11. Maeda S, Hsu L, Liu H, et al. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 2005; 307: 734-8.
12. Kosovac K, Brenmoehl J, Holler E, et al. Association of the NOD2 genotype with bacterial translocation via altered cell-cell contacts in Crohn's disease patients. Inflamm Bowel Dis 2010; 16: 1311-2.
13. Seiderer J, Schnitzler F, Brand S, et al. Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis. Scand J Gastroenterol 2006; 41: 1421-32.
14. Economou M, Trikalinos TA, Loizou KT, Tsianos EV, Ioannidis JPA. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol 2004; 99: 2393-404.
15. Brenmoehl J, Herfarth H, Glück T, et al. Genetic variants in the NOD2/CARD15 gene are associated with early mortality in sepsis patients. Intensive Care Med 2007; 33: 1541-8.
16. Holler E, Rogler G, Brenmoehl J, et al. The role of genetic variants of NOD2/CARD15, a receptor of the innate immune system, in GvHD and complications following related and unrelated donor haematopoietic stem cell transplantation. Int J Immunogenet 2008; 35: 381-4.
17. Appenrodt B, Grünhage F, Gentemann MG, et al. Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis. Hepatology 2010; 51: 1327-33.
18. Evans LT, Kim WR, Poterucha JJ, Kamath PS. Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites. Hepatology 2003; 37: 897-901.
19. Inohara N, Ogura Y, Fontalba A, et al. Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2. J Biol Chem 2003; 278: 5509-12.
20. Ekman A, Cardell LO. The expression and function of Nod-like receptors in neutrophils. Immunology 2010; 130: 55-63.
21. Runyon BA. Management of adult patients with ascites due to cirrhosis. Hepatology 2004; 39: 841-56.
22. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-9.
23. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-70.
24. Hampe J, Grebe J, Nikolaus S, et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet 2002; 359: 1661-5.
25. Dupont WD, Plummer WD. Power and sample size calculations for studies involving linear regression. Control Clin Trials 1998; 19: 589-601.
26. Bruns T, Sachse S, Straube E, et al. Identification of bacterial DNA in neutrocytic and non-neutrocytic cirrhotic ascites by means of a multiplex polymerase chain reaction. Liver Int 2009; 29: 1206-14.
27. Hugot J, Zaccaria I, Cavanaugh J, et al. Prevalence of CARD15/NOD2 mutations in Caucasian healthy people. Am J Gastroenterol 2007; 102: 1259-67.
28. Navasa M, Follo A, Filella X, et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology 1998; 27: 1227-32.
29. Kamani L, Mumtaz K, Ahmed US, Ali AW, Jafri W. Outcomes in culture positive and culture negative ascitic fluid infection in patients with viral cirrhosis: cohort study. BMC Gastroenterol 2008; 8: 59.
30. Chu CM, Chang KY, Liaw YF. Prevalence and prognostic significance of bacterascites in cirrhosis with ascites. Dig Dis Sci 1995; 40: 561-5.
31. Castellote J. Spontaneous bacterial peritonitis and reagent strips. Hepatology 2007; 46: 1667-8; author reply 1669-70.
32. Fernández J, Navasa M, Gómez J, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002; 35: 140-8.
33. Cholongitas E, Papatheodoridis GV, Lahanas A, et al. Increasing frequency of Gram-positive bacteria in spontaneous bacterial peritonitis. Liver Int 2005; 25: 57-61.
34. Girardin SE, Boneca IG, Viala J, et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003; 278: 8869-72.
35. Deshmukh HS, Hamburger JB, Ahn SH, et al. Critical role of NOD2 in regulating the immune response to Staphylococcus aureus. Infect Immun 2009; 77: 1376-82.